Israel Corp chairman steps down, to be vice chair of Teva Pharm

Reuters

JERUSALEM, Dec 10 (Reuters) - Israeli conglomerate IsraelCorp said on Tuesday its chairman Amir Elstein willstep down at the end of the year after 3-1/2 years in the post.

Elstein, who will continue to be an unpaid advisor to theboard of directors, will be replaced by Ron Moskovitz, adirector since 2008.

Separately, Teva Pharmaceutical Industries, theworld's largest generic drugmaker, said it named Elstein as itsvice chairman effective Jan. 1 after Moshe Many resigned forpersonal reasons.

Israel Corp also said Elstein would remain as chairman ofTower Semiconductor, which is partly owned by thecompany.

View Comments (0)